Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001779453-19-000004
Filing Date
2019-11-29
Accepted
2019-11-29 12:41:25
Documents
1
Period of Report
2019-05-09

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3/A  
1 PRIMARY DOCUMENT primary_doc.xml 3/A 5843
  Complete submission text file 0001779453-19-000004.txt   7749
Mailing Address 269 EAST GRAND AVE SOUTH SAN FRANCISCO CA 94080
Business Address 269 EAST GRAND AVE SOUTH SAN FRANCISCO CA 94080 415-910-5717
Cortexyme, Inc. (Issuer) CIK: 0001662774 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address ONE LOMBARD STREET, SUITE 200 SAN FRANCISCO CA 94111
Business Address
Boeding Chad (Reporting) CIK: 0001779451 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-38890 | Film No.: 191260632

Mailing Address ONE LOMBARD STREET, SUITE 200 SAN FRANCISCO CA 94111
Business Address ONE LOMBARD STREET, SUITE 200 SAN FRANCISCO CA 94111 415-433-3751
EPIQ Capital Group, LLC (Reporting) CIK: 0001779453 (see all company filings)

State of Incorp.: CA | Fiscal Year End: 1231
Type: 3/A | Act: 34 | File No.: 001-38890 | Film No.: 191260633